Amarex Website Jan 18, 2021. Client Cytodyn...Ama
Post# of 148340
Client Cytodyn...Amarex president and CEO Dr. Kazem Kazempour stated "We are expediting ALL Covid-19 clinical trials so that treatments will be available to patients as rapidly as possible. We have completed phase 2..Blah..Blah..with mild to moderate and working on IND submission Phase3 trial for Pro140 for long-haulers Covid-19 patients.
Sept 10, 2021, Phase 2 for long-haulers...Blah..Blah>>Amarex and AIM Immunotech.
Wait until AIM gets wind of our lawsuit...I see feathers flying..